Medicine
Megestrol 20 mg tablet
Megestrol 20 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Megestrol
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 50 pouches
- Manufacturers
- Strides PharmaIndiaRemedyrepackTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02AB01 Megestrol
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 October 1996
- Identifiers
- RxCUI 860215, 860221DailyMed set ID 66573d39-f2a7-49fd-9ed2-97ac8f6e8456, 8ec70070-da70-4a38-9d58-cf2278517661, 7d74ac91-5fe3-4e21-81f2-e484e2a18548NDC 0555-0606, 64380-158, 70518-4640Application ANDA074621, ANDA072422
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 64380-158-01 | Strides PharmaIndia | 11 April 2022 |
| 100 tablet in 1 bottle | 0555-0606-02 | Teva Pharmaceuticals | 25 October 1996 |
| 50 pouch in 1 box / 1 tablet in 1 pouch | 70518-4640-0 | Remedyrepack | 27 April 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 August 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Megestrol
Clinical summary
Megestrol is a progestin indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). It is available as oral suspension and tablets. MedsAcross supplies Megestrol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MegestrolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Megestrol Acetate prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Megestrol 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.